Time required to initiate outbreak and pandemic observational research

Journal of Critical Care

Volumn 40, Issue , 2017, Pages 7-10

  Rishu, Asgar H ^a   Marinoff, Nicole ^a   Julien, Lisa ^b   Dumitrascu, Mariana ^c   Marten, Nicole ^d   Eggertson, Shauna ^d   Willems, Su ^e   Ruddell, Stacy ^f   Lane, Dan ^f   Light, Bruce ^d   Stelfox, Henry T ^f   Jouvet, Philippe ^c   Hall, Richard ^b   Reynolds, Steven ^e   Daneman, Nick ^a   Fowler, Robert A ^g  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Canada; Critical; Intensive care; Outbreak; Pandemic; Research

Indexed keywords

ARTICLE; DATA ANALYSIS; DISEASE SURVEILLANCE; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; EPIDEMIC; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; MEDICAL RESEARCH; MIDDLE EAST RESPIRATORY SYNDROME; OBSERVATIONAL STUDY; RESEARCH ETHICS; ZIKA FEVER; ZIKA VIRUS; BENCHMARKING; CLINICAL TRIAL; COMMUNICABLE DISEASE; METHODOLOGY; MULTICENTER STUDY; ONTARIO; PANDEMIC;

BENCHMARKING; COMMUNICABLE DISEASES, EMERGING; EPIDEMIOLOGIC METHODS; HUMANS; OBSERVATIONAL STUDIES AS TOPIC; ONTARIO; PANDEMICS; RESEARCH DESIGN;

EID: 85020711246     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.02.009     Document Type: Article

References (28)

1. Kilbourne, E.D., Influenza pandemics of the 20th century. Emerg Infect Dis 12:1 (2006), 9–14.
2. Fowler, R.A., Abdelmalik, P., Wood, G., Foster, D., Gibney, N., Bandrauk, N., et al. Critical care capacity in Canada: results of a national cross-sectional study. Crit Care, 19, 2015, 133.
3. Christian, M.D., Hawryluck, L., Wax, R.S., Cook, T., Lazar, N.M., Herridge, M.S., et al. Development of a triage protocol for critical care during an influenza pandemic. CMAJ 175:11 (2006), 1377–1381.
4. Eastman, N., Philips, B., Rhodes, A., Triaging for adult critical care in the event of overwhelming need. Intensive Care Med 36:6 (2010), 1076–1082.
5. Fowler, R.A., Lapinsky, S.E., Hallett, D., Detsky, A.S., Sibbald, W.J., Slutsky, A.S., et al. Critically ill patients with severe acute respiratory syndrome. JAMA 290:3 (2003), 367–373.
6. Kumar, A., Zarychanski, R., Pinto, R., Cook, D.J., Marshall, J., Lacroix, J., et al., Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 302:17 (2009), 1872–1879.
7. Schieffelin, J.S., Shaffer, J.G., Goba, A., Gbakie, M., Gire, S.K., Colubri, A., et al., KGH Lassa Fever Program, Viral Hemorrhagic Fever Consortium, WHO Clinical Response Team, Clinical illness and outcomes in patients with Ebola in Sierra Leone. N Engl J Med 371:22 (2014), 2092–2100.
8. Assiri, A., McGeer, A., Perl, T.M., Price, C.S., Al Rabeeah, A.A., Cummings, D.A., et al., KSA MERS-CoV Investigation Team, Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369:5 (2013), 407–416.
9. Fowler, R.A., Webb, S.A., Rowan, K.M., Sprung, C.L., Thompson, B.T., Randolph, A.G., et al. Early observational research and registries during the 2009-2010 influenza A pandemic. Crit Care Med 38:Suppl. 4 (2010), e120–e132.
10. Levy, M.M., Baylor, M.S., Bernard, G.R., Fowler, R., Franks, T.J., Hayden, F.G., et al. Clinical issues and research in respiratory failure from severe acute respiratory syndrome. Am J Respir Crit Care Med 171:5 (2005), 518–526.
11. Aoyama, K., Fowler, R.A., The challenges of treating Ebola virus disease with experimental therapies. Lancet Respir Med 3:7 (2015), 503–504.
12. Dominguez-Cherit, G., De la Torre, A., Rishu, A., Pinto, R., Ñamendys-Silva, S.A., Camacho-Ortiz, A., et al. Influenza A (H1N1pdm09)–related critical illness and mortality in Mexico and Canada. Crit Care Med, 2014 [in press].
13. Hall, D.E., Hanusa, B.H., Stone, R.A., Ling, B.S., Arnold, R.M., Time required for institutional review board review at one veterans affairs medical center. JAMA Surg 150:2 (2015), 103–109.
14. De Feo, G., Frontini, L., Rota, S., Pepe, A., Signoriello, S., Labianca, R., et al. Time required to start multicentre clinical trials within the Italian medicine agency programme of support for independent research. J Med Ethics 41:10 (2015), 799–803.
15. Wang-Gillam, A., Williams, K., Novello, S., Gao, F., Scagliotti, G.V., Govindan, R., Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the Atlantic. J Clin Oncol 28:24 (2010), 3803–3807.
16. Green, L.A., Lowery, J.C., Kowalski, C.P., Wyszewianski, L., Impact of institutional review board practice variation on observational health services research. Health Serv Res 41:1 (2006), 214–230.
17. Dziak, K., Anderson, R., Sevick, M.A., Weisman, C.S., Levine, D.W., Scholle, S.H., Variations among institutional review board reviews in a multisite health services research study. Health Serv Res 40:1 (2005), 279–290.
18. Kenyon, G.M., Mendelow, A.D., Gregson, B.A., Rowan, E., Obtaining regulatory approval for multicentre randomised controlled trials: experiences in the STICH II trial. Br J Neurosurg 25:3 (2011), 352–356.
19. International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC). https://isaric.tghn.org/protocols/ [accessed 11.07.16].
20. Orchard, J., For debate: should observational clinical studies require ethics committee approval?. J Sci Med Sport 11:3 (2008), 239–242.
21. Moser, B., Röggla, G., Should observational clinical studies require ethics committee approval?. J Sci Med Sport, 11(5), 2008, 518.
22. Neff, M.J., Institutional review board consideration of chart reviews, case reports, and observational studies. Respir Care 53:10 (2008), 1350–1353.
23. Kaufmann, P., O'Rourke, P.P., Central institutional review board review for an academic trial network. Acad Med 90:3 (2015), 321–323.
24. Platform for European Preparedness Against (Re-)emerging Epidemics (PREPARE). http://www.prepare-europe.eu [accessed 12.12.16].
25. Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). http://www.glopid-r.org [accessed 12.12.16].
26. Cook, D., Burns, K., Finfer, S., Kissoon, N., Bhagwanjee, S., Annane, D., et al. Clinical research ethics for critically ill patients: a pandemic proposal. Crit Care Med 38:Suppl. 4 (2010 Apr), e138–e142.
27. Gobat, N.H., Gal, M., Francis, N.A., Hood, K., Watkins, A., Turner, J., et al. Key stakeholder perceptions about consent to participate in acute illness research: a rapid, systematic review to inform epi/pandemic research preparedness. Trials, 16, 2015, 591.
28. iDataFax user guide, Clinical DataFax systems Inc. http://clarityrand.mcmaster.ca/datafax/ [accessed 12.12.16].